Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 3
2020 3
2021 7
2022 7
2023 21
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Development of Tumor Markers for Breast Cancer Immunotherapy.
Fang Q, Shen G, Xie Q, Guan Y, Liu X, Ren D, Zhao F, Liu Z, Ma F, Zhao J. Fang Q, et al. Among authors: ren d. Curr Mol Med. 2024;24(5):547-564. doi: 10.2174/1566524023666230508152817. Curr Mol Med. 2024. PMID: 37157196 Review.
Male Breast Cancer: Three Case Reports and a Literature Review.
Xin Y, Wang F, Ren D, Zhao F, Zhao J. Xin Y, et al. Among authors: ren d. Anticancer Agents Med Chem. 2023;23(19):2161-2169. doi: 10.2174/1871520623666230821124008. Anticancer Agents Med Chem. 2023. PMID: 37605409 Review.
Expression and clinical prognostic value of CYB561 in breast cancer.
Zhou X, Shen G, Ren D, Guo X, Han J, Guo Q, Zhao F, Wang M, Dong Q, Li Z, Zhao J. Zhou X, et al. Among authors: ren d. J Cancer Res Clin Oncol. 2022 Aug;148(8):1879-1892. doi: 10.1007/s00432-022-03928-z. Epub 2022 Apr 29. J Cancer Res Clin Oncol. 2022. PMID: 35486183
44 results